Literature DB >> 9860923

Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.

F P Guengerich1, N A Hosea, A Parikh, L C Bell-Parikh, W W Johnson, E M Gillam, T Shimada.   

Abstract

Today cytochrome P450 (P450) research is accepted as an integral part of drug development and discovery. Work leading to this point included biochemical studies on P450 in experimental animal models and application to human systems. The development of recombinant expression systems has been an important part of the progress, and in this article we describe some recently developed bacterial systems that can be used for the production of metabolites, genotoxicity testing, and screening in random mutagenesis work. Rate-limiting aspects of P450 reactions vary with particular systems, and further investigations are in order. Non-ionic detergents have been utilized widely in P450 purification work; these compounds are now shown to be substrates for P450s. These oxidations are not only of fundamental interest in expanding the repertoire of P450 substrates but have significance in light of human exposure to these compounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860923

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).

Authors:  K Pachkoria; M I Lucena; F Ruiz-Cabello; E Crespo; M R Cabello; R J Andrade
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

Review 2.  [Drug interactions in geriatric medicine].

Authors:  Angela Storka; Johannes Pleiner
Journal:  Wien Med Wochenschr       Date:  2009

3.  Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

4.  Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

5.  Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.

Authors:  Kirsty J McLean; Nigel S Scrutton; Andrew W Munro
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

6.  Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

Authors:  Vandana Hirani; Anton Yarovoy; Anita Kozeska; Ronald P Magnusson; Jerome M Lasker
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

7.  Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism.

Authors:  Lauren L Richards-Waugh; Donald A Primerano; Yulia Dementieva; James C Kraner; Gary O Rankin
Journal:  J Anal Toxicol       Date:  2014-10       Impact factor: 3.367

8.  Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.

Authors:  Ganesh S Moorthy; Harini Jogiraju; Christina Vedar; Athena F Zuppa
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-09-28       Impact factor: 3.205

9.  The effect of pioglitazone on pharmacokinetics of carbamazepine in healthy rabbits.

Authors:  Issam Abushammala
Journal:  Saudi Pharm J       Date:  2014-07-08       Impact factor: 4.330

10.  Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide.

Authors:  Christine Mölzer; Hedwig Huber; Andrea Steyrer; Gesa V Ziesel; Marlies Wallner; Hung T Hong; Joanne T Blanchfield; Andrew C Bulmer; Karl-Heinz Wagner
Journal:  J Nat Prod       Date:  2013-10-11       Impact factor: 4.050

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.